Your activity: 64 p.v.
your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Pharmacologic mechanisms of crystal meth

Pharmacologic mechanisms of crystal meth
Schematic diagram of the human dopamine-rich striatum, which is made up of the caudate nucleus, putamen and ventral striatum (left), and a striatal dopamine nerve ending (right). This coronal slice is taken at the rostral tip of the anterior commissure. Methamphetamine causes dopamine release from the nerve endings. The areas of the brain responsible for methamphetamine-liking and craving are unknown but probably include the striatum and regions that provide input to the striatum. Normally, dopamine released into the synapse is taken back up into the nerve ending by the dopamine transporter and is transported into the synaptic vesicle by the vesicular monoamine transporter 2. Methamphetamine causes the release of striatal dopamine from the nerve ending into the synapse. This likely involves the translocation of dopamine from the synaptic vesicle to the neuronal cytoplasm via the vesicular monoamine transporter 2 and the reverse transport of dopamine from the cytoplasm into the synapse via the dopamine transporter.
Reproduced with permission from: Kish SJ. Pharmacologic mechanisms of crystal meth. CMAJ 2008; 178:1679. Copyright © 2008 Canadian Medical Association. This work is protected by copyright and the making of this copy was with the permission of Access Copyright. Any alteration of its content or further copying in any form whatsoever is strictly prohibited unless otherwise permitted by law.
Graphic 87703 Version 3.0